ChoA Pharmaceutical Co., LTD.

₩1,566As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:034940Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (22.93%)
Div yield —
ROE (11.81%)
Pharmaceutical Preparations
Beta (5Y) 0.63
PE TTM —
TSR TTM (71.40%)
Mkt cap ₩9.703B
ROIC (4.63%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩1,501
(4.15%)
(90.49%)
Hold 1|8|7|6|5
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
21.06
21.23
23.65
25.24
13.65%
5.03%
18.26%
29.88%
Revenue₩M
712.0
734.1
753.7
770.1
(2.41%)
1.01%
6.45%
5.39%
Peers (US$7.154M)
Cap (US$)
PE
12.83M
—
7.534M
0.101x
Capital
TTM
5Y
10Y
Leveragex
2.322
(0.605)
(0.522)
EBIT/Intx
0.468
0.160
0.169
Own earn%
321.37
232.69
159.16
Sh yield%
43.54
51.01
51.36
Owners
Insiders/Inst%
5.23
51.95
Short interest%
0.76
SBC / revenue%
1.16
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
0–6
$1 testx
0.0
Incr. ROIC%
1